Crossmark

Balloon-occluded versus conventional transarterial chemoembolization for the treatment of early to intermediate stage hepatocellular carcinoma: a meta-analysis and trial sequential analysis

Crossref DOI link: https://doi.org/10.1186/s12885-025-14435-y

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Jiaxi

Wang, Weiwei

Zhai, Huan

Ma, Yanan

You, Qiwen

Shao, Haibo
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No.82072037, 82372070, 82111530100)

Liaoning Medical-Engineering Cross Fund (2022-YGJC-53)
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 30 January 2025

Accepted: 3 June 2025

First Online: 1 July 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below